Treating current COVID-19 patients with antibody-containing blood plasma from people who have recovered from the disease continues to be studied

Early findings from a large international clinical trial suggest severely ill COVID-19 patients do not benefit from an experimental therapy involving infusions of blood plasma from those who have recovered from the disease. This particular arm of the study was halted, but the trial will continue to investigate the treatment in moderately ill patients.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , ,